首页 | 本学科首页   官方微博 | 高级检索  
     


Prospective randomized trial of sclerotherapy vs standard treatment for epistaxis due to hereditary hemorrhagic telangiectasia
Authors:Holly Boyer MD  Patricia Fernandes DDS  MS  Chap Le PhD  Bevan Yueh MD
Affiliation:1. Department of Otolaryngology – Head and Neck Surgery, University of Minnesota Medical School, University of Minnesota, Minneapolis, MN;2. Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN
Abstract:
Keywords:hemorrhagic disorders  epistaxis  sclerotherapy  sodium tetradecyl sulfate  Osler-Weber-Rendu syndrome
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号